<code id='88A7ED3094'></code><style id='88A7ED3094'></style>
    • <acronym id='88A7ED3094'></acronym>
      <center id='88A7ED3094'><center id='88A7ED3094'><tfoot id='88A7ED3094'></tfoot></center><abbr id='88A7ED3094'><dir id='88A7ED3094'><tfoot id='88A7ED3094'></tfoot><noframes id='88A7ED3094'>

    • <optgroup id='88A7ED3094'><strike id='88A7ED3094'><sup id='88A7ED3094'></sup></strike><code id='88A7ED3094'></code></optgroup>
        1. <b id='88A7ED3094'><label id='88A7ED3094'><select id='88A7ED3094'><dt id='88A7ED3094'><span id='88A7ED3094'></span></dt></select></label></b><u id='88A7ED3094'></u>
          <i id='88A7ED3094'><strike id='88A7ED3094'><tt id='88A7ED3094'><pre id='88A7ED3094'></pre></tt></strike></i>

          knowledge

          knowledge

          author:fashion    Page View:383
          The Blue Shield of California headquarters building is seen in San Francisco – health care policy from STAT
          Eric Risberg/AP

          Two dominant Blue Cross Blue Shield companies in California intentionally underreported premiums of certain health plans so they could avoid paying Affordable Care Act taxes, according to new federal whistleblower complaints.

          These claims renew concerns about whether health insurance companies have skirted the tax code and to what extent tax fraud could exist in the industry.

          advertisement

          Blue Shield of California evaded $111 million in taxes between 2016 and 2020, according to a complaint that was filed with the Internal Revenue Service on June 27. Elevance Health, the parent company of Anthem Blue Cross in California, evaded $60 million in taxes during the same time period, according to a separate complaint filed with the IRS.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          An exit interview with Bristol Myers Squibb CEO Giovanni Caforio
          An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

          OutgoingBristolCEOGiovanniCaforioEmiliePickeringforSTATIt’schangingoftheguardtimeatpharmaceuticalgia

          read more
          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more

          An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

          OutgoingBristolCEOGiovanniCaforioEmiliePickeringforSTATIt’schangingoftheguardtimeatpharmaceuticalgia